We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.74B
AUM Growth
-$403M
Cap. Flow
-$540M
Cap. Flow %
-14.42%
Top 10 Hldgs %
17.64%
Holding
421
New
67
Increased
59
Reduced
163
Closed
53

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$85.4M
2
NXPI icon
NXP Semiconductors
NXPI
+$53.8M
3
APTV icon
Aptiv
APTV
+$47.1M
4
MON
Monsanto Co
MON
+$42.2M
5
BLK icon
Blackrock
BLK
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 17.7%
3 Consumer Discretionary 16.53%
4 Energy 10.05%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIG icon
351
Transocean
RIG
$6.63B
$187K 0.01%
11,600
-11,600
-50% -$209K
MSFT icon
352
Microsoft
MSFT
$3.69T
$177K ﹤0.01%
4,000
APC
353
DELISTED
Anadarko Petroleum
APC
$156K ﹤0.01%
2,000
-34,000
-94% -$2.94M
PEP icon
354
PepsiCo
PEP
$185B
$149K ﹤0.01%
1,600
CPRI icon
355
Capri Holdings
CPRI
$1.6B
$145K ﹤0.01%
3,450
-3,450
-50% -$194K
INTC icon
356
Intel
INTC
$513B
$143K ﹤0.01%
4,700
-7,630
-62% -$247K
CSCO icon
357
Cisco
CSCO
$434B
$137K ﹤0.01%
5,000
DE icon
358
Deere & Co
DE
$184B
$136K ﹤0.01%
1,400
AGN
359
DELISTED
Allergan Inc
AGN
$134K ﹤0.01%
+441
New +$134K
CAT icon
360
Caterpillar
CAT
$360B
$127K ﹤0.01%
1,500
ABBV icon
361
AbbVie
ABBV
$465B
$121K ﹤0.01%
1,800
ABT icon
362
Abbott
ABT
$177B
$88K ﹤0.01%
1,800
MCD icon
363
McDonald's
MCD
$179B
$76K ﹤0.01%
800
BTU
364
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$71K ﹤0.01%
2,159
PH icon
365
Parker-Hannifin
PH
$117B
$58K ﹤0.01%
500
CDK
366
DELISTED
CDK Global, Inc.
CDK
$54K ﹤0.01%
1,000
WBA
367
DELISTED
Walgreens Boots Alliance
WBA
$41K ﹤0.01%
480
SYK icon
368
Stryker
SYK
$108B
$32K ﹤0.01%
340
ADEA icon
369
Adeia
ADEA
$2.75B
-975,988
Closed -$10.4M
ALSN icon
370
Allison Transmission
ALSN
$10.1B
-146,740
Closed -$4.69M
ANIP icon
371
ANI Pharmaceuticals
ANIP
$1.66B
-154,401
Closed -$9.66M
BC icon
372
Brunswick
BC
$4.46B
-276,025
Closed -$14.2M
BDX icon
373
Becton Dickinson
BDX
$50.6B
-370
Closed -$52K
BLK icon
374
Blackrock
BLK
$164B
-101,230
Closed -$37M
BMY icon
375
Bristol-Myers Squibb
BMY
$130B
-27,700
Closed -$1.79M

Similar funds

Castleark Management's Q2 2015 Portfolio in Review

As of Q2 2015, Castleark Management held 421 positions worth $3.74B, down 9.7% from $4.15B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Castleark Management withdrew a net $540M in Q2 2015, closing 53 positions and reducing 163 holdings. Its most notable exit was Blackrock, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $36.2M.

  • Castleark Management's largest Q2 2015 buy was Morgan Stanley: 932,120 shares worth $36.2M.
  • Castleark Management added most to Amazon in Q2 2015, an estimated $26.4M increase.
  • Castleark Management's biggest Q2 2015 reduction was Medtronic, cutting an estimated $85.4M.
  • Castleark Management fully exited Blackrock in Q2 2015, selling an estimated $37M.
  • Castleark Management's ten largest holdings make up 18% of its $3.74B portfolio in Q2 2015.
  • Castleark Management opened 67 new positions and closed 53 in Q2 2015.
  • Castleark Management's portfolio value fell 9.7% quarter-over-quarter to $3.74B.

Based on Castleark Management's 13F filing for Q2 2015, filed 17 Aug 2015.